BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 16628725)

  • 1. Torsades de pointes upon fluconazole administration in a patient with acute myeloblastic leukemia.
    Tatetsu H; Asou N; Nakamura M; Hanaoka N; Matsuno F; Horikawa K; Mitsuya H
    Am J Hematol; 2006 May; 81(5):366-9. PubMed ID: 16628725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Torsades de pointes associated with voriconazole use.
    Philips JA; Marty FM; Stone RM; Koplan BA; Katz JT; Baden LR
    Transpl Infect Dis; 2007 Mar; 9(1):33-6. PubMed ID: 17313469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long QTc interval and torsade de pointes caused by fluconazole.
    Pham CP; de Feiter PW; van der Kuy PH; van Mook WN
    Ann Pharmacother; 2006; 40(7-8):1456-61. PubMed ID: 16849620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Torsade de pointes during sevoflurane anesthesia and fluconazole infusion in a patient with long QT syndrome. A case report.
    Tacken MC; Bracke FA; Van Zundert AA
    Acta Anaesthesiol Belg; 2011; 62(2):105-8. PubMed ID: 21919379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Torsades de Pointes ventricular tachycardia in a pediatric patient treated with fluconazole.
    Esch JJ; Kantoch MJ
    Pediatr Cardiol; 2008 Jan; 29(1):210-3. PubMed ID: 17849073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluconazole-induced torsade de pointes.
    Tholakanahalli VN; Potti A; Hanley JF; Merliss AD
    Ann Pharmacother; 2001 Apr; 35(4):432-4. PubMed ID: 11302406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Voriconazole-induced QT interval prolongation and ventricular tachycardia: a non-concentration-dependent adverse effect.
    Alkan Y; Haefeli WE; Burhenne J; Stein J; Yaniv I; Shalit I
    Clin Infect Dis; 2004 Sep; 39(6):e49-52. PubMed ID: 15472801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Torsades de pointes complicating pentamidine therapy of Pneumocystis carinii pneumonia in acute myelogenous leukemia.
    Otsuka M; Kanamori H; Sasaki S; Taguchi J; Harano H; Ogawa K; Matsuzaki M; Mohri H; Okubo T; Sumita S; Ochiai H
    Intern Med; 1997 Oct; 36(10):705-8. PubMed ID: 9372331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. QT prolongation and Torsades de Pointes in patients previously treated with anthracyclines.
    Arbel Y; Swartzon M; Justo D
    Anticancer Drugs; 2007 Apr; 18(4):493-8. PubMed ID: 17351403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The perfect storm: Torsades de Pointes in a child with leukemia.
    Bagatell R; Hainstock M; Lowe MC; Barber BJ; Samson RA
    Pediatr Blood Cancer; 2007 Dec; 49(7):996-9. PubMed ID: 16333840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Long QT and torsade de pointes in a patient with acquired human immunodeficiency virus infection in multitherapy with drugs affecting cytochrome P450].
    Hrovatin E; Zardo F; Brieda M; Dametto E; Piazza R; Antonini-Canterin F; Cassin M; Meneguzzo N; Viel E; Lestuzzi C; Di Gennaro G; Nicolosi GL
    Ital Heart J Suppl; 2004 Sep; 5(9):735-40. PubMed ID: 15568612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ketoconazole induced torsades de pointes without concomitant use of QT interval-prolonging drug.
    Mok NS; Lo YK; Tsui PT; Lam CW
    J Cardiovasc Electrophysiol; 2005 Dec; 16(12):1375-7. PubMed ID: 16403073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness analysis of antifungal treatment for patients on chemotherapy.
    Nomura K; Kawasugi K; Morimoto T
    Eur J Cancer Care (Engl); 2006 Mar; 15(1):44-50. PubMed ID: 16441676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Candidiasis of the liver following successful chemotherapy of acute myeloid leukemia (Fab type 6) and recovery with oral fluconazole therapy].
    Keiser G; Schmid M; Ishak KG; Wirth W; Vogt M
    Schweiz Med Wochenschr; 1996 Apr; 126(17):713-7. PubMed ID: 8668982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Torsade de pointes induced by systemic antifungal agents: lessons from a retrospective analysis of published case reports.
    Justo D; Zeltser D
    Mycoses; 2006 Nov; 49(6):463-70. PubMed ID: 17022762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluconazole- and levofloxacin-induced torsades de pointes in an intensive care unit patient.
    Gandhi PJ; Menezes PA; Vu HT; Rivera AL; Ramaswamy K
    Am J Health Syst Pharm; 2003 Dec; 60(23):2479-83. PubMed ID: 14686224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Torsades de pointes in a patient receiving fluconazole for cerebral cryptococcosis.
    McMahon JH; Grayson ML
    Am J Health Syst Pharm; 2008 Apr; 65(7):619-23. PubMed ID: 18359968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concomitant use of levofloxacin and fluconazole leading to possible torsades de pointes.
    Tilton JJ; Sadr R; Groo VL
    J Oncol Pharm Pract; 2019 Dec; 25(8):2004-2006. PubMed ID: 30501378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. QT interval prolongation and torsades de pointes due to a coadministration of metronidazole and amiodarone.
    Kounas SP; Letsas KP; Sideris A; Efraimidis M; Kardaras F
    Pacing Clin Electrophysiol; 2005 May; 28(5):472-3. PubMed ID: 15869686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long QT syndrome and torsade de pointes in a patient receiving fluconazole.
    Wassmann S; Nickenig G; Böhm M
    Ann Intern Med; 1999 Nov; 131(10):797. PubMed ID: 10577320
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.